# Fintepla

NDC: 43376-322
Generic name: fenfluramine
Labeler / Manufacturer: UCB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20200715

FDA application: NDA212102

## Active ingredients

- FENFLURAMINE: 2.2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43376-322"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43376-322
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e88f360e-33ad-4cd6-b2de-5ef885857c5d